9.24
price down icon0.43%   -0.04
pre-market  Vorhandelsmarkt:  9.16   -0.08   -0.87%
loading
Schlusskurs vom Vortag:
$9.28
Offen:
$9.2
24-Stunden-Volumen:
564.70K
Relative Volume:
0.63
Marktkapitalisierung:
$706.39M
Einnahmen:
$54.55M
Nettoeinkommen (Verlust:
$-193.57M
KGV:
-3.1972
EPS:
-2.89
Netto-Cashflow:
$-181.86M
1W Leistung:
+12.14%
1M Leistung:
-1.07%
6M Leistung:
-22.22%
1J Leistung:
-58.88%
1-Tages-Spanne:
Value
$9.09
$9.41
1-Wochen-Bereich:
Value
$8.20
$9.41
52-Wochen-Spanne:
Value
$8.18
$29.56

Nurix Therapeutics Inc Stock (NRIX) Company Profile

Name
Firmenname
Nurix Therapeutics Inc
Name
Telefon
(415) 660-5320
Name
Adresse
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Name
Mitarbeiter
286
Name
Twitter
Name
Nächster Verdiensttermin
2025-04-09
Name
Neueste SEC-Einreichungen
Name
NRIX's Discussions on Twitter

Vergleichen Sie NRIX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NRIX
Nurix Therapeutics Inc
9.24 709.45M 54.55M -193.57M -181.86M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-17 Eingeleitet Leerink Partners Market Perform
2024-12-10 Eingeleitet BTIG Research Buy
2024-12-06 Eingeleitet BMO Capital Markets Outperform
2024-10-24 Eingeleitet UBS Buy
2024-10-11 Eingeleitet Jefferies Buy
2024-09-06 Fortgesetzt Robert W. Baird Outperform
2024-07-31 Eingeleitet Truist Buy
2023-06-26 Fortgesetzt Oppenheimer Outperform
2023-03-09 Eingeleitet Barclays Overweight
2023-02-28 Eingeleitet Oppenheimer Outperform
2022-10-11 Eingeleitet Morgan Stanley Equal-Weight
2022-05-31 Hochstufung Wells Fargo Equal Weight → Overweight
2022-02-10 Eingeleitet Wells Fargo Equal Weight
2021-12-29 Eingeleitet H.C. Wainwright Buy
2021-10-14 Eingeleitet SVB Leerink Outperform
2021-06-04 Fortgesetzt Robert W. Baird Outperform
2021-04-30 Fortgesetzt Piper Sandler Overweight
2021-04-30 Eingeleitet RBC Capital Mkts Outperform
2021-04-14 Eingeleitet Berenberg Buy
2020-11-19 Eingeleitet Robert W. Baird Outperform
2020-08-18 Eingeleitet JP Morgan Overweight
2020-08-18 Eingeleitet Needham Buy
2020-08-18 Eingeleitet Piper Sandler Overweight
2020-08-18 Eingeleitet Stifel Buy
Alle ansehen

Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten

pulisher
Sep 30, 2025

Technical analysis overview for Nurix Therapeutics Inc. stock2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

How Nurix Therapeutics Inc. stock performs in weak economyMarket Performance Summary & Reliable Volume Spike Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Using AI based signals to follow Nurix Therapeutics Inc.2025 Major Catalysts & Smart Allocation Stock Tips - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Subdued Growth No Barrier To Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) Price - simplywall.st

Sep 30, 2025
pulisher
Sep 30, 2025

Does Nurix Therapeutics Inc. qualify in momentum factor screeningWeekly Profit Summary & Weekly Momentum Picks - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What momentum shifts mean for Nurix Therapeutics Inc.Earnings Miss & Real-Time Sentiment Analysis - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

What drives Nurix Therapeutics Inc stock priceCovered Call Writing & Fast Growing Portfolio Trading - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Nurix Therapeutics Inc.’s volatility index tracking explainedPortfolio Value Report & Verified Short-Term Trading Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Nurix Therapeutics Inc. stock trend forecastPortfolio Performance Report & Long-Term Capital Growth Strategies - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Using Bollinger Bands to evaluate Nurix Therapeutics Inc.Day Trade & Reliable Breakout Stock Forecasts - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about Nurix Therapeutics Inc stockGrowth vs. Value Investing & Free Trading Psychology Coaching - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

What margin trends mean for Nurix Therapeutics Inc. stockWeekly Risk Summary & Smart Allocation Stock Reports - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

What MACD and RSI say about Nurix Therapeutics Inc.Trade Risk Assessment & Expert Curated Trade Setups - newser.com

Sep 28, 2025
pulisher
Sep 26, 2025

Nurix Therapeutics (NASDAQ:NRIX) Shares Up 4.6%Time to Buy? - MarketBeat

Sep 26, 2025
pulisher
Sep 25, 2025

Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock? - Yahoo Finance

Sep 25, 2025
pulisher
Sep 23, 2025

RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛

Sep 23, 2025
pulisher
Sep 23, 2025

Nurix Therapeutics, Inc. (NRIX) Reports Q3 Loss, Lags Revenue Estimates - MSN

Sep 23, 2025
pulisher
Sep 22, 2025

Nurix Therapeutics’ SWOT analysis: promising pipeline drives biotech stock outlook - Investing.com Nigeria

Sep 22, 2025
pulisher
Sep 21, 2025

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Nurix Therapeutics (NASDAQ:NRIX) Shares Up 6.5%Should You Buy? - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Aug Final Week: Is Nurix Therapeutics Inc forming a double bottomProduct Launch & Low Drawdown Trading Strategies - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Goldman Sachs Group Inc. Has $6.03 Million Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat

Sep 20, 2025
pulisher
Sep 19, 2025

Is Nurix Therapeutics Inc stock good for income investorsMarket Weekly Review & Fast Gain Stock Trading Tips - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Published on: 2025-09-19 19:28:52 - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Growth Value: Can Nurix Therapeutics Inc scale operations efficientlyTrade Analysis Summary & AI Forecasted Entry and Exit Points - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Market Recap: Is Telefnica Brasil SA Depositary Receipts ROE strong enoughSell Signal & Reliable Trade Execution Plans - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Published on: 2025-09-19 16:56:26 - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Nurix Therapeutics (NRIX) Receives a Buy from Stifel Nicolaus - The Globe and Mail

Sep 19, 2025
pulisher
Sep 19, 2025

What candlestick patterns are forming on Nurix Therapeutics Inc.Weekly Investment Recap & AI Based Buy and Sell Signals - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Nurix Therapeutics (NRIX) Gets a Buy from Barclays - The Globe and Mail

Sep 19, 2025
pulisher
Sep 19, 2025

Can volume confirm reversal in Nurix Therapeutics Inc.2025 Big Picture & Real-Time Price Movement Reports - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Using Ichimoku Cloud for Nurix Therapeutics Inc. technicalsWeekly Profit Analysis & Smart Allocation Stock Reports - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Predicting Nurix Therapeutics Inc. trend using moving averagesPortfolio Performance Summary & AI Based Buy/Sell Signal Reports - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

US Market Recap: Is Nurix Therapeutics Inc forming a double bottomJuly 2025 Rallies & Weekly Market Pulse Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Reactions: Whats the RSI of Nurix Therapeutics Inc stockJuly 2025 Decliners & Trade Opportunity Analysis Reports - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $35 - 富途牛牛

Sep 18, 2025
pulisher
Sep 18, 2025

Barclays Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $31 - 富途牛牛

Sep 18, 2025
pulisher
Sep 18, 2025

Smart tools for monitoring Nurix Therapeutics Inc.’s price actionWeekly Profit Report & Accurate Buy Signal Notifications - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Short interest data insights for Nurix Therapeutics Inc.July 2025 Outlook & Stepwise Trade Signal Implementation - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Using RSI to spot recovery in Nurix Therapeutics Inc.Weekly Risk Summary & AI Enhanced Trading Signals - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Nurix Therapeutics Inc. recovery potential after sell offTrade Entry Summary & Free Daily Entry Point Trade Alerts - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis - Investing News Network

Sep 17, 2025
pulisher
Sep 17, 2025

Nurix Therapeutics Advances GS-6791 into Clinical Testing for Inflammatory Diseases with Preclinical Data Presented at EADV Congress - Quiver Quantitative

Sep 17, 2025
pulisher
Sep 17, 2025

Near-Complete IRAK4 Knockdown: Nurix's Novel Dermatitis Drug Shows Breakthrough Results in Preclinical Study - Stock Titan

Sep 17, 2025
pulisher
Sep 17, 2025

Pattern recognition hints at Nurix Therapeutics Inc. upsideTreasury Yields & Technical Analysis for Trade Confirmation - newser.com

Sep 17, 2025
pulisher
Sep 16, 2025

Aug Volume: Should I buy Nurix Therapeutics Inc stock nowWeekly Profit Recap & Weekly Chart Analysis and Trade Guides - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Earnings Report: Is Nurix Therapeutics Inc. stock good for income investorsWeekly Trade Recap & Fast Exit/Entry Strategy Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Summary: What is the long term forecast for Nurix Therapeutics Inc stock2025 Investor Takeaways & Daily Profit Maximizing Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Inflation Data: Is Nurix Therapeutics Inc a stock for growth or value investorsJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - خودرو بانک

Sep 16, 2025

Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Kapitalisierung:     |  Volumen (24h):